首页> 外文期刊>Evolution: International Journal of Organic Evolution >DEFEATING PATHOGEN DRUG RESISTANCE: GUIDANCE FROM EVOLUTIONARY THEORY
【24h】

DEFEATING PATHOGEN DRUG RESISTANCE: GUIDANCE FROM EVOLUTIONARY THEORY

机译:降低抗药性:进化论的指导

获取原文
获取原文并翻译 | 示例
       

摘要

Many of the greatest challenges in medicine and public health involve the evolution of drug resistance by pathogens. Recent advances in the theory of natural selection suggest that there are two broad classes of pathogen traits that can be targeted by drugs or vaccines. The first class, consisting of traits that benefit the individual organisms bearing them, causes a strong evolutionary response and the rapid emergence of drug resistance. The second class, consisting of traits that benefit groups of pathogen organisms including the individual provider, causes a weaker evolutionary response and less drug resistance. Although most previous drug development has targeted the first class, it would be advantageous to focus on the second class as targets for drug and vaccine development. Specific examples and test cases are discussed.
机译:在医学和公共卫生领域,许多最大的挑战涉及病原体对耐药性的演变。自然选择理论的最新进展表明,药物或疫苗可以靶向两大类病原体性状。第一类包括使携带它们的单个生物受益的性状,可引起强烈的进化反应并迅速产生耐药性。第二类包括对包括个体提供者在内的病原生物群有益的性状,导致较弱的进化反应和较小的耐药性。尽管以前的大多数药物开发都针对第一类药物,但将第二类药物作为药物和疫苗开发的靶标将是有利的。讨论了特定的示例和测试用例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号